Do analysts rate INDV or BMY?

Bloomsbury Publishing has a consensus target price of GBX 800, indicating a potential upside of 24.14%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, analysts plainly believe Bloomsbury Publishing is more favorable than Indivior. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Indivior 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bloomsbury Publishing 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts prefer BMY or HCM?

Bloomsbury Publishing presently has a consensus price target of GBX 800, suggesting a potential upside of 24.14%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, equities analysts clearly believe Bloomsbury Publishing is more favorable than HUTCHMED. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bloomsbury Publishing 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 HUTCHMED 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Bloomsbury Publishing (BMY) Competitors

GBX 644.43 +9.43 (+1.49%)

As of 12:03 PM Eastern

Compare

BMY vs. INDV, HCM, GRI, SLS, and ERGO

Should you buy Bloomsbury Publishing stock or one of its competitors? MarketBeat compares Bloomsbury Publishing with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bloomsbury Publishing include Indivior (INDV), HUTCHMED (HCM), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), and Ergomed (ERGO). These companies are all part of the "pharmaceutical products" industry.

How does Bloomsbury Publishing compare to Indivior?

Indivior (LON:INDV) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

Indivior has a net margin of 11.44% compared to Bloomsbury Publishing's net margin of 8.28%. Bloomsbury Publishing's return on equity of 12.74% beat Indivior's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Indivior	11.44%	-23.90%	2.37%
Bloomsbury Publishing	8.28%	12.74%	7.82%

86.0% of Indivior shares are held by institutional investors. Comparatively, 42.9% of Bloomsbury Publishing shares are held by institutional investors. 3.4% of Indivior shares are held by insiders. Comparatively, 3.6% of Bloomsbury Publishing shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Bloomsbury Publishing has a consensus target price of GBX 800, indicating a potential upside of 24.14%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, analysts plainly believe Bloomsbury Publishing is more favorable than Indivior.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Indivior	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Indivior's average media sentiment score of 0.00 equaled Bloomsbury Publishing'saverage media sentiment score.

Company	Overall Sentiment
Indivior	Neutral
Bloomsbury Publishing	Neutral

Bloomsbury Publishing has lower revenue, but higher earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Indivior	£1.40B	1.38	-£2.36M	-£1.21	N/A
Bloomsbury Publishing	£325.90M	1.60	£37.37M	£32.80	19.65

Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.2%. Bloomsbury Publishing pays an annual dividend of GBX 15.62 per share and has a dividend yield of 2.4%. Indivior pays out -1,243.7% of its earnings in the form of a dividend. Bloomsbury Publishing pays out 47.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Indivior has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.419, suggesting that its stock price is 58% less volatile than the broader market.

Summary

Bloomsbury Publishing beats Indivior on 12 of the 16 factors compared between the two stocks.

How does Bloomsbury Publishing compare to HUTCHMED?

Bloomsbury Publishing (LON:BMY) and HUTCHMED (LON:HCM) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

HUTCHMED has a net margin of 163.84% compared to Bloomsbury Publishing's net margin of 8.28%. HUTCHMED's return on equity of 36.88% beat Bloomsbury Publishing's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bloomsbury Publishing	8.28%	12.74%	7.82%
HUTCHMED	163.84%	36.88%	-5.90%

Bloomsbury Publishing has higher earnings, but lower revenue than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bloomsbury Publishing	£325.90M	1.60	£37.37M	£32.80	19.65
HUTCHMED	£548.51M	2.69	-£52.98M	£53.00	3.24

Bloomsbury Publishing has a beta of 0.419, indicating that its stock price is 58% less volatile than the broader market. Comparatively, HUTCHMED has a beta of 0.428, indicating that its stock price is 57% less volatile than the broader market.

In the previous week, HUTCHMED had 2 more articles in the media than Bloomsbury Publishing. MarketBeat recorded 2 mentions for HUTCHMED and 0 mentions for Bloomsbury Publishing. Bloomsbury Publishing's average media sentiment score of 0.00 beat HUTCHMED's score of -0.40 indicating that Bloomsbury Publishing is being referred to more favorably in the media.

Company	Overall Sentiment
Bloomsbury Publishing	Neutral
HUTCHMED	Neutral

Bloomsbury Publishing presently has a consensus price target of GBX 800, suggesting a potential upside of 24.14%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, equities analysts clearly believe Bloomsbury Publishing is more favorable than HUTCHMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
HUTCHMED	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

42.9% of Bloomsbury Publishing shares are held by institutional investors. Comparatively, 20.4% of HUTCHMED shares are held by institutional investors. 3.6% of Bloomsbury Publishing shares are held by insiders. Comparatively, 2.8% of HUTCHMED shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Bloomsbury Publishing beats HUTCHMED on 9 of the 16 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Grainger?

Grainger (LON:GRI) and Bloomsbury Publishing (LON:BMY) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Grainger pays an annual dividend of GBX 7.86 per share and has a dividend yield of 4.5%. Bloomsbury Publishing pays an annual dividend of GBX 15.62 per share and has a dividend yield of 2.4%. Grainger pays out 28.8% of its earnings in the form of a dividend. Bloomsbury Publishing pays out 47.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Grainger is clearly the better dividend stock, given its higher yield and lower payout ratio.

Grainger has a beta of 0.777, meaning that its share price is 22% less volatile than the broader market. Comparatively, Bloomsbury Publishing has a beta of 0.419, meaning that its share price is 58% less volatile than the broader market.

Grainger currently has a consensus target price of GBX 225.60, indicating a potential upside of 29.06%. Bloomsbury Publishing has a consensus target price of GBX 800, indicating a potential upside of 24.14%. Given Grainger's higher probable upside, equities analysts clearly believe Grainger is more favorable than Bloomsbury Publishing.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Grainger	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Grainger has a net margin of 54.91% compared to Bloomsbury Publishing's net margin of 8.28%. Bloomsbury Publishing's return on equity of 12.74% beat Grainger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Grainger	54.91%	6.53%	2.14%
Bloomsbury Publishing	8.28%	12.74%	7.82%

48.1% of Grainger shares are held by institutional investors. Comparatively, 42.9% of Bloomsbury Publishing shares are held by institutional investors. 1.5% of Grainger shares are held by insiders. Comparatively, 3.6% of Bloomsbury Publishing shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Bloomsbury Publishing has higher revenue and earnings than Grainger. Grainger is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Grainger	£238.20M	5.42	-£1.11M	£27.30	6.40
Bloomsbury Publishing	£325.90M	1.60	£37.37M	£32.80	19.65

In the previous week, Grainger had 7 more articles in the media than Bloomsbury Publishing. MarketBeat recorded 7 mentions for Grainger and 0 mentions for Bloomsbury Publishing. Grainger's average media sentiment score of 1.46 beat Bloomsbury Publishing's score of 0.00 indicating that Grainger is being referred to more favorably in the media.

Company	Overall Sentiment
Grainger	Positive
Bloomsbury Publishing	Neutral

Summary

Grainger beats Bloomsbury Publishing on 10 of the 18 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Standard Life UK Smaller Companies Trust?

Bloomsbury Publishing (LON:BMY) and Standard Life UK Smaller Companies Trust (LON:SLS) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

Bloomsbury Publishing currently has a consensus target price of GBX 800, suggesting a potential upside of 24.14%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, equities research analysts clearly believe Bloomsbury Publishing is more favorable than Standard Life UK Smaller Companies Trust.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Standard Life UK Smaller Companies Trust	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Bloomsbury Publishing has a net margin of 8.28% compared to Standard Life UK Smaller Companies Trust's net margin of 0.00%. Bloomsbury Publishing's return on equity of 12.74% beat Standard Life UK Smaller Companies Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bloomsbury Publishing	8.28%	12.74%	7.82%
Standard Life UK Smaller Companies Trust	N/A	N/A	N/A

42.9% of Bloomsbury Publishing shares are held by institutional investors. 3.6% of Bloomsbury Publishing shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Bloomsbury Publishing has higher revenue and earnings than Standard Life UK Smaller Companies Trust. Standard Life UK Smaller Companies Trust is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bloomsbury Publishing	£325.90M	1.60	£37.37M	£32.80	19.65
Standard Life UK Smaller Companies Trust	£222.48M	0.00	N/A	£217.40	N/A

In the previous week, Bloomsbury Publishing's average media sentiment score of 0.00 equaled Standard Life UK Smaller Companies Trust'saverage media sentiment score.

Company	Overall Sentiment
Bloomsbury Publishing	Neutral
Standard Life UK Smaller Companies Trust	Neutral

Bloomsbury Publishing pays an annual dividend of GBX 15.62 per share and has a dividend yield of 2.4%. Standard Life UK Smaller Companies Trust pays an annual dividend of GBX 0.08 per share. Bloomsbury Publishing pays out 47.6% of its earnings in the form of a dividend. Standard Life UK Smaller Companies Trust pays out 0.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Bloomsbury Publishing beats Standard Life UK Smaller Companies Trust on 11 of the 13 factors compared between the two stocks.

How does Bloomsbury Publishing compare to Ergomed?

Bloomsbury Publishing (LON:BMY) and Ergomed (LON:ERGO) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Bloomsbury Publishing currently has a consensus price target of GBX 800, suggesting a potential upside of 24.14%. Given Bloomsbury Publishing's stronger consensus rating and higher probable upside, equities research analysts plainly believe Bloomsbury Publishing is more favorable than Ergomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bloomsbury Publishing	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Ergomed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Bloomsbury Publishing's average media sentiment score of 0.00 equaled Ergomed'saverage media sentiment score.

Company	Overall Sentiment
Bloomsbury Publishing	Neutral
Ergomed	Neutral

42.9% of Bloomsbury Publishing shares are held by institutional investors. Comparatively, 71.1% of Ergomed shares are held by institutional investors. 3.6% of Bloomsbury Publishing shares are held by company insiders. Comparatively, 18.2% of Ergomed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Bloomsbury Publishing has higher revenue and earnings than Ergomed. Ergomed is trading at a lower price-to-earnings ratio than Bloomsbury Publishing, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bloomsbury Publishing	£325.90M	1.60	£37.37M	£32.80	19.65
Ergomed	£152.09M	0.00	£15M	£0.29	N/A

Bloomsbury Publishing has a beta of 0.419, indicating that its share price is 58% less volatile than the broader market. Comparatively, Ergomed has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market.

Ergomed has a net margin of 9.87% compared to Bloomsbury Publishing's net margin of 8.28%. Ergomed's return on equity of 18.08% beat Bloomsbury Publishing's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bloomsbury Publishing	8.28%	12.74%	7.82%
Ergomed	9.87%	18.08%	10.16%

Summary

Ergomed beats Bloomsbury Publishing on 7 of the 13 factors compared between the two stocks.

Get Bloomsbury Publishing News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMY vs. The Competition

Export

Metric	Bloomsbury Publishing	Publishing Industry	Communication Sector	LON Exchange
Market Cap	£520.98M	£1.36B	£3.53B	£2.84B
Dividend Yield	2.58%	8.52%	6.77%	6.17%
P/E Ratio	19.65	55.76	15.00	368.18
Price / Sales	1.60	58.40	102.73	84,612.72
Price / Cash	8.91	15.71	16.06	27.87
Price / Book	2.59	1.19	4.92	7.49
Net Income	£37.37M	£59.19M	-£9.17M	£5.89B
7 Day Performance	0.54%	-0.87%	0.68%	-0.48%
1 Month Performance	-1.21%	3.06%	-1.33%	-1.00%
1 Year Performance	30.58%	-8.63%	-5.49%	61.74%

Bloomsbury Publishing Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMY Bloomsbury Publishing	2.1823 of 5 stars	GBX 644.43 +1.5%	GBX 800 +24.1%	+29.1%	£520.98M	£325.90M	19.65	34,300	Gap Down
INDV Indivior	N/A	GBX 1,238 +1.6%	N/A	+8.4%	£1.93B	£1.40B	N/A	1,000	Gap Up High Trading Volume
HCM HUTCHMED	N/A	GBX 172.50 +1.2%	N/A	-30.1%	£1.48B	£548.51M	3.25	1,760
GRI Grainger	4.7359 of 5 stars	GBX 170.70 +0.4%	GBX 225.60 +32.2%	-15.7%	£1.26B	£238.20M	6.25	372	Positive News
SLS Standard Life UK Smaller Companies Trust	N/A	N/A	N/A	N/A	£715.41M	£222.48M	3.37	10

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:BMY) was last updated on 7/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bloomsbury Publishing (BMY) Competitors

BMY vs. INDV, HCM, GRI, SLS, and ERGO

How does Bloomsbury Publishing compare to Indivior?

Summary

How does Bloomsbury Publishing compare to HUTCHMED?

Summary

How does Bloomsbury Publishing compare to Grainger?

Summary

How does Bloomsbury Publishing compare to Standard Life UK Smaller Companies Trust?

Summary

How does Bloomsbury Publishing compare to Ergomed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMY vs. The Competition

Bloomsbury Publishing Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bloomsbury Publishing (BMY) Competitors

BMY vs. INDV, HCM, GRI, SLS, and ERGO

How does Bloomsbury Publishing compare to Indivior?

Is INDV or BMY more profitable?

Do institutionals and insiders hold more shares of INDV or BMY?

Do analysts rate INDV or BMY?

Does the media favor INDV or BMY?

Which has preferable valuation & earnings, INDV or BMY?

Is INDV or BMY a better dividend stock?

Which has more volatility & risk, INDV or BMY?

Summary

How does Bloomsbury Publishing compare to HUTCHMED?

Is BMY or HCM more profitable?

Which has stronger earnings and valuation, BMY or HCM?

Which has more volatility & risk, BMY or HCM?

Does the media prefer BMY or HCM?

Do analysts prefer BMY or HCM?

Do insiders & institutionals have more ownership in BMY or HCM?

Summary

How does Bloomsbury Publishing compare to Grainger?

Is GRI or BMY a better dividend stock?

Which has more volatility & risk, GRI or BMY?

Do analysts rate GRI or BMY?

Is GRI or BMY more profitable?

Do insiders and institutionals hold more shares of GRI or BMY?

Which has higher valuation and earnings, GRI or BMY?

Does the media prefer GRI or BMY?

Summary

How does Bloomsbury Publishing compare to Standard Life UK Smaller Companies Trust?

Do analysts rate BMY or SLS?

Is BMY or SLS more profitable?

Do insiders & institutionals believe in BMY or SLS?

Which has stronger valuation & earnings, BMY or SLS?

Does the media refer more to BMY or SLS?

Is BMY or SLS a better dividend stock?

Summary

How does Bloomsbury Publishing compare to Ergomed?

Do analysts prefer BMY or ERGO?

Does the media refer more to BMY or ERGO?

Do institutionals and insiders hold more shares of BMY or ERGO?

Which has stronger valuation and earnings, BMY or ERGO?

Which has more volatility and risk, BMY or ERGO?

Is BMY or ERGO more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMY vs. The Competition

Bloomsbury Publishing Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools